Contact us

SeqOne S.A.S

SeqOne S.A.S.
C/IRMB - Hopital St Eloi
80 Avenue Augustin Fliche
34090 Montpellier France
Jean-Marc Holder
+33 6 03 24 57 56

SeqOne raises €3m to accelerate the adoption of genetic testing in healthcare

SeqOne announces a three million euro funding round led by Elaia with IRDI / SORIDEC and supported by BPI France.  The funding will accelerate the development of SeqOne’s genetic analysis platform combining AI and big data approaches to  make genetic analysis more accessible to doctors treating cancer and hereditary diseases. [Dateline: Montpellier 28/03/2019]  Chronic conditions […]

> Read the full article here

SeqOne lève €3m euros pour mettre les tests génomiques au service du diagnostic et de la médecine personnalisée

Montpellier, le 28 mars 2019 La start-up montpelliéraine de bioinformatique SeqOne annonce une levée de fonds de 3 millions d’euros mené par Elaia avec la participation de l’Irdi-Soridec et BPI France. Ce financement en equity permettra à SeqOne d’accélérer le développement de sa plateforme d’analyse et d’interprétation des données issues du séquençage du génome et […]

> Read the full article here

Molecular yoga: How DNA works

A great video showing how DNA works during cell replication.

> Read the full article here

Canadian and French startups announce genomics partnership to better diagnose rare disease

  February 28th, 2018: Paris, France & Toronto, Canada Gene42 Inc., a Toronto company that develops software for precision medicine, and SeqOne, a French life science company providing genomic data analysis solutions for healthcare, announced their partnership to accelerate rare disease diagnosis. There are roughly 7,000 rare diseases, with patients waiting on average 5–7 years […]

> Read the full article here

SeqOne wins prestigious iLab grant to improve genomics analysis software in healthcare

Montpellier 12th of July, 2017:  SeqOne a French start-up in the genomic medicine market is proud to announce that it has been awarded an i-Lab grant by the Ministry of Education and Technology.  i-Lab is a national competition open to all French start-ups designed to identify the most promising technical innovations by France’s most forward-thinking […]

> Read the full article here

FDA approves gene-altering leukemia therapy in US

The New York times today reported that the FDA had approved the first therapy that involves human genetic modification.   The procedure developed by Novartis to combat leukemia will be the first gene therapy ever to reach the market in the US.  Read the full article here.

> Read the full article here

CRISPR gene editing technology tested on a human

The following video was featured in an article in that talks about the first efforts to genetically engineer humans.  You can read the article here.

> Read the full article here

Next generation genomic analysis for next generation healthcare